Insider Selling: Mark Murphy Unloads 4,200 Shares of St. Jude Medical Stock (STJ)
St. Jude Medical (NYSE:STJ) VP Mark Murphy sold 4,200 shares of the stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $53.50, for a total transaction of $224,700.00. Following the transaction, the vice president now directly owns 642 shares of the company’s stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
A number of research firms have recently commented on STJ. Analysts at Wells Fargo & Co. upgraded shares of St. Jude Medical (NYSE:STJ) from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, August 9th. Separately, analysts at TheStreet reiterated a “buy” rating on shares of St. Jude Medical (NYSE:STJ) in a research note to investors on Friday, July 19th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical (NYSE:STJ) in a research note to investors on Friday, July 19th. They now have a $54.00 price target on the stock.
Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the company’s stock. St. Jude Medical has a consensus rating of “Hold” and an average target price of $47.05.
St. Jude Medical (NYSE:STJ) traded down 0.51% during mid-day trading on Friday, hitting $52.82. 908,503 shares of the company’s stock traded hands. St. Jude Medical has a 52 week low of $30.25 and a 52 week high of $54.06. The stock has a 50-day moving average of $52.19 and a 200-day moving average of $45.92. The company has a market cap of $15.169 billion and a price-to-earnings ratio of 25.08.
St. Jude Medical (NYSE:STJ) last released its earnings data on Wednesday, July 17th. The company reported $0.96 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.94 by $0.02. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the prior year, the company posted $0.86 earnings per share. The company’s quarterly revenue was down .5% on a year-over-year basis. On average, analysts predict that St. Jude Medical will post $3.72 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Thursday, October 31st. Shareholders of record on Monday, September 30th will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 1.88%. The ex-dividend date of this dividend is Thursday, September 26th.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.